Press Resease

Batten Disease Treatment Market by Disease Type (Infantile, Late Infantile, Juvenile and Adult) and by Therapy Type includes Occupational Therapy and Physical Therapy: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2023

Published Date: 27-Mar-2018 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-2722 Status : Published

Global batten disease treatment market expected to reach USD 41.39 million by the end of 2023, growing at the CAGR of around 2.79% between 2018 and 2023. Global Batten disease treatment market is primarily driven by the increased prevalence of disease, increase in R&D and clinical trial are expected to fuel the market.

Description

The report covers forecast and analysis for the batten disease treatment market on a global and regional level. The study provides historic data of 2017 along with a forecast from 2018 to 2023 based revenue (USD Million) the study includes drivers and restraints for the batten disease treatment market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the batten disease treatment market on a global level.

In order to give the users of this report a comprehensive view on the batten disease treatment market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis. Wherein test type segments and therapy segments are benchmarked based on their market size, growth, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the players in the market. In addition, the report also covers key strategic developments of the market including acquisitions and mergers, new technology launch, agreements, partnerships collaborations& joint ventures, research & development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, disease portfolio of various companies according to the region.

Global Batten disease treatment market

The study provides a decisive view on the batten disease treatment market by segmenting the market based on disease type and therapy type and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2023. Based on disease market is segmented into Infantile NCL, Late Infantile NCL, Juvenile NCL, and Adult NCL. Therapy type covered in this report includes occupational and physical therapies. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa with its further bifurcation into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for Batten disease treatment market based on disease type and therapies in all the regions and countries.

The reports also include detailed profiles of end players such as ReGenX Biosciences LLC, BioMarin Pharmaceuticals, and SenebBioSciences Inc. 

This report segments the global batten disease treatment market as follows: 

Global Batten Disease Treatment Market: Disease Type Segment Analysis

  • Infantile NCL
  • Late Infantile NCL
  • Juvenile NCL
  • Adult NCL

Global Batten Disease Treatment Market: Therapy type Segment Analysis
Occupational Therapy 
Physical Therapy
Global Batten Disease Treatment Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Batten Disease Treatment market, 2017 - 2023 (USD Million)
    • 2.2. Global Batten Disease Treatment market: Snapshot
  •  
  • Chapter 3. Batten Disease Treatment - Market Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Batten Disease Treatment market drivers: Impact analysis
      • 3.2.2. Increase in the prevalence of Batten disease
      • 3.2.3. Increase in research and development
    • 3.3. Market Restraints
      • 3.3.1. Global Batten Disease Treatment market restraints: Impact analysis
      • 3.3.2. Lack of awareness
    • 3.4. Opportunities
      • 3.4.1. Drug Discovery and Drug launch
    • 3.5. Porter's five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat of new entrants
      • 3.5.4. The threat of new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by disease type segment
      • 3.6.2. Market attractiveness analysis, by therapy segment
      • 3.6.3. Market attractiveness analysis, by regional segment
  •  
  • Chapter 4. Global Batten Disease Treatment Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Batten Disease Treatment market: company market share, 2017
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research & Development, and Regional Expansion
    • 4.3. Price Trend Analysis
    • 4.4. Technology Portfolio
  •  
  • Chapter 5. Global Batten Disease Treatment Market -Disease Type Segment Analysis
    • 5.1. Global Batten Disease Treatment market: Disease Type overview
      • 5.1.1. Global Batten Disease Treatment market revenue share, by disease Type, 2017 and 2023
    • 5.2. Infantile NCL
  •  
  • Chapter 6. Global Infantile NCL Treatment market, 2017 - 2023(USD Million)
    • 6.1. Late Infantile NCL
      • 6.1.1. Global late infantile NCL Disease Treatment market, 2017 - 2023(USD Million)
    • 6.2. Juvenile NCL
      • 6.2.1. Global juvenile NCL Treatment market, 2017 - 2023(USD Million)
    • 6.3. Adult NCL
      • 6.3.1. Global adult NCL Treatment market , 2017 - 2023(USD Million)
  •  
  • Chapter 7. Global Batten Disease Treatment Market - Therapy Segment Analysis
    • 7.1. Global Batten Disease Treatment market: Therapyoverview
      • 7.1.1. Global Batten Disease Treatment market revenue share, by Therapy, 2017 and 2023
    • 7.2. Occupational therapy
      • 7.2.1. Global Batten Disease Treatment market by occupational therapy, 2017 - 2023 (USD Million)
    • 7.3. Physical Therapy
      • 7.3.1. Global Batten Disease Treatment market for physical therapy,2017 - 2023(USD Million)
  •  
  • Chapter 8. Global Batten Disease Treatment Market - Regional Segment Analysis
    • 8.1. Global Batten Disease Treatment market: Regional overview
      • 8.1.1. Global Batten Disease Treatment market revenue share, by region, 2017 and 2023
    • 8.2. North America
      • 8.2.1. North America Batten Disease Treatment market revenue, by Disease type, 2014 - 2023 (USD Million)
      • 8.2.2. North America Batten Disease Treatment market revenue, by Therapy, 2014 - 2023 (USD Million)
      • 8.2.3. U.S.
        • 8.2.3.1. U.S. Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
        • 8.2.3.2. U.S. Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
      • 8.2.4. Canada
        • 8.2.4.1. Canada Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
        • 8.2.4.2. Canada Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
      • 8.2.5. Rest of North America
        • 8.2.5.1. Rest of North America Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
        • 8.2.5.2. Rest of North America Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
    • 8.3. Europe
      • 8.3.1. Europe Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
      • 8.3.2. Europe Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
      • 8.3.3. Germany
        • 8.3.3.1. Germany Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
        • 8.3.3.2. Germany Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
      • 8.3.4. France
        • 8.3.4.1. France Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
        • 8.3.4.2. France Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
      • 8.3.5. UK
        • 8.3.5.1. UK Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
        • 8.3.5.2. UK Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
      • 8.3.6. Italy
        • 8.3.6.1. Italy Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
        • 8.3.6.2. Italy Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
      • 8.3.7. Spain
        • 8.3.7.1. Spain Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
        • 8.3.7.2. Spain Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
      • 8.3.8. Russia
        • 8.3.8.1. Russia Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
        • 8.3.8.2. Russia Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
      • 8.3.9. Rest of Europe
        • 8.3.9.1. Rest of Europe Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
        • 8.3.9.2. Rest of Europe Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Batten Disease Treatment market revenue, by disease type, 2014 - 2023, (USD Million)
      • 8.4.2. Asia Pacific Batten Disease Treatment market revenue, by therapy, 2014 - 2023, (USD Million)
      • 8.4.3. China
        • 8.4.3.1. China Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
        • 8.4.3.2. China Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
      • 8.4.4. Japan
        • 8.4.4.1. Japan Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
        • 8.4.4.2. Japan Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
      • 8.4.5. India
        • 8.4.5.1. India Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
        • 8.4.5.2. India Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
      • 8.4.6. Australia
        • 8.4.6.1. Australia Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
        • 8.4.6.2. Australia Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
      • 8.4.7. Rest of Asia Pacific
        • 8.4.7.1. Rest of Asia Pacific Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
        • 8.4.7.2. Rest of Asia Pacific Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
      • 8.5.2. Latin America Batten Disease Treatment market revenue, by therapy, 2014 - 2023(USD Million)
      • 8.5.3. Mexico
        • 8.5.3.1. Mexico Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
        • 8.5.3.2. Mexico Batten Disease Treatment market revenue, by therapy, 2014 - 2023 (USD Million)
      • 8.5.4. Brazil
        • 8.5.4.1. Brazil Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
        • 8.5.4.2. Brazil Batten Disease Treatment market revenue, by therapy, 2014 - 2023 (USD Million)
      • 8.5.5. Argentina
        • 8.5.5.1. Argentina Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
        • 8.5.5.2. Argentina Batten Disease Treatment market revenue, by therapy, 2014 - 2023 (USD Million)
      • 8.5.6. Rest of Latin America
        • 8.5.6.1. Rest of Latin America Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
        • 8.5.6.2. Rest of Latin America Batten Disease Treatment market revenue, by therapy, 2014 - 2023 (USD Million)
      • 8.6. Middle East and Africa
        • 8.6.1. Middle East and Africa Batten Disease Treatment market revenue, by disease type, 2014 - 2023 (USD Million)
        • 8.6.2. Middle East and Africa Batten Disease Treatment market revenue, by therapy, 2014 - 2023 (USD Million)
        • 8.6.3. Saudi Arabia
          • 8.6.3.1. Saudi Arabia Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
          • 8.6.3.2. Saudi Arabia Batten Disease Treatment market revenue, by therapy, 2014 - 2023 (USD Million)
        • 8.6.4. UAE
          • 8.6.4.1. UAE Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
          • 8.6.4.2. UAE Batten Disease Treatment market revenue, by therapy, 2014 - 2023 (USD Million)
        • 8.6.5. South Africa
          • 8.6.5.1. South Africa Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
          • 8.6.5.2. South Africa Batten Disease Treatment market revenue, by therapy, 2014 - 2023 (USD Million)
        • 8.6.6. Qatar
          • 8.6.6.1. Qatar Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
          • 8.6.6.2. Qatar Batten Disease Treatment market revenue, by therapy, 2014 - 2023 (USD Million)
        • 8.6.7. Rest of Middle East & Africa
          • 8.6.7.1. Rest of Middle East & Africa Batten Disease Treatment market revenue, by disease type, 2014 - 2023(USD Million)
          • 8.6.7.2. Rest of Middle East & Africa Batten Disease Treatment market revenue, by therapy, 2014 - 2023 (USD Million)
  •  
  • Chapter 9. Company Profile
    • 9.1. ReGenX Biosciences LLC
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Disease type portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. BioMarin Pharmaceuticals
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Disease type portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. SenebBioSciences Inc.
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Disease type portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Batten Disease Treatment market. Zion Market Research has collected and analyzed key data belong to the global Batten Disease Treatment market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account while estimating market size. The revenue generated by the leading industry participants in from the sales of Batten Disease Treatment across the world has been calculated through primary and secondary research.

Zion Market Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Market Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in the validation of findings from secondary research and to understand key trends in the Batten Disease Treatment industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases, and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Batten Disease Treatment market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split into segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage, and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

Batten disease is also known as Neuronal Ceroid Lipofuscinoses (NCL), which is a very rare, fatal, life-threatening autosomal, genetically inherited disorder. This disorder is caused due to the abnormality of genes which are required to synthesize the required protein. This affects children and mostly observed in juvenile phase due to the mutation of CLN3 gene. This disorder leads to genetic mutations which result in neurological impairment, loss of motor skills, seizures, loss of ability to communicate and walk visual impairments and others. In this disorder, genetic mutations interrupt the ability of cells to dispose of the wastes. This disease can be diagnosed with the help of different medical examinations which include blood and urine test, MRI, DNA analysis, electroencephalogram, and skin or tissue sampling. This disease, fall under the category of lysosome storage disorder.

Batten disease treatment market is driven by the increased prevalence of Batten disease and it led to increases in patient educations programs to increase awareness among people. National Institutes are taking up the initiative in R&D for the development of batten disease cure. There is an increase in healthcare infrastructure and expenditure results in the increase of batten disease treatment market. There is no effective cure for this disease, few drugs and vitamins are available which reduces the symptoms and companies are involved in the discovery of effective drug.

Global Batten disease treatment market

Recently in 2017, FDA has approved Brineura (Cerliponase Alfa) for the treatment of Batten disease. This drug slows downs the loss of walking ability. There are ongoing clinical trials for the various drug that can be used for the treatment include rhTPP 1 (BMN 190)and other drugs. There is no established cure or prevention for this disease and symptoms of this disease take a long time to be noticed are the factors expected to affect the growth of batten disease treatment market.

Based on the disease type batten disease treatment market is segmented into Infantile NCL, Late Infantile NCL, Juvenile NCL, and Adult NCL. Further, based on therapies batten disease treatment market is segmented into occupational and physical therapies for the treatment.

North America is expected to dominate the batten disease treatment market closely followed by Europe over the forecast period. Due to the increased prevalence of Batten disease in these regions and increase in clinical trials, and increased awareness in these regions are expected to support the growth of the market. Asia Pacific market is expected to grow moderately due to lack of awareness among people and manufacturers. Latin America and Middle East Africa are expected to grow considerably over the forecast period.

Some key players of batten disease treatment market include ReGenX Biosciences LLC, BioMarin Pharmaceuticals, and SenebBioSciences Inc.  

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com